Nuvalent elects Dr. Michael L. Meyers to the Board as Class II director

Nuvalent, Inc.

Dr. Meyers was elected independent Class II director effective October 4, 2022.
He will also serve on the Nominating and Corporate Governance Committee.
Received initial option grant for 40,000 shares at $19.48 per share, vesting monthly over 3 years.
Compensation follows Nuvalent's non-employee director policy including annual cash retainers and equity.
No family relationships or transactions with the Company requiring disclosure.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael L. Meyers

Director

NUVL · Nuvalent, Inc.

Effective: 2022-10-04
Filed: October 6, 2022, 7:59 PM ET

On October 4, 2022, in accordance with the recommendation of the Nominating and Corporate Governance Committee (“NCG Committee”) of the Board of Directors (the “Board”) of Nuvalent, Inc. (the “Company”), the Board elected Michael L. Meyers, M.D., Ph.D., as a member of the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael L. Meyers was elected as Director at Nuvalent, Inc..

Action: elected
Role: Director

Exact text from the filing

On October 4, 2022, in accordance with the recommendation of the Nominating and Corporate Governance Committee (“NCG Committee”) of the Board of Directors (the “Board”) of Nuvalent, Inc. (the “Company”), the Board elected Michael L. Meyers, M.D., Ph.D., as a member of the Board, effective immediately.

View on SEC.gov

Nuvalent, Inc. filing history →

Source: SEC EDGAR

accession 0001564590-22-033704

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.